Simponi (also known by its generic name golimumab) is a TNF-alpha inhibitor that was approved by the FDA in April 2009 to treat adults with active psoriatic arthritis. It is also approved for rheumatoid arthritis and ankylosing spondylitis.
Patients take Simponi by giving themselves an injection under the skin once a month. Simponi is designed to be taken continuously to maintain improvement.
To learn more, please visit the Simponi website.